We have investigated the lipid polylysine core peptide (LCP) system as a self-adjuvanting group A streptococcal (GAS) vaccine delivery approach. LCP constructs were synthesised incorporating peptides from the M protein conserved carboxy terminal C-repeat region, the amino terminal type-specific region and from both of these regions. Immunisation with the constructs without adjuvant led to the induction of peptide-specific serum IgG antibody responses, heterologous opsonic antibodies, and complete protection from GAS infection. These data indicate that protective immunity to GAS infection can be evoked using the self-adjuvanting LCP system, and point to the potential application of this system in human mucosal GAS vaccine development. (c) 20...
Despite the broad knowledge about the pathogenicity of Streptococcus pyogenes there is still a contr...
We investigated the efficacy of a synthetic Streptococcus pyogenes vaccine targeting two virulence f...
This study demonstrates the effectiveness of a novel self-adjuvanting vaccine delivery system for mu...
Background & objectives: To develop a broad strain coverage GAS vaccine, several strategies have...
Preclinical studies carried out over the last seven years by our group have focused on the developme...
Background & objectives: To develop a broad strain coverage GAS vaccine, several strategies have bee...
Traditional vaccines consisting of whole attenuated micro-organisms. or microbial components adminis...
A lipoamino acid based synthetic peptide, (Lipid Core Peptide, LCP) derived from the conserved regio...
Background. We investigated the lipid core peptide (LCP) system for mucosal vaccine delivery against...
Lipoamino acid-based synthetic peptides (lipid core peptides, LCP) derived from the type-specific an...
Lipid core peptide (LCP)-based group A streptococcal (GAS) vaccines incorporating numerous GAS M-pro...
The study reported here investigated the immunogenicity and protective potential of a lipid core pep...
Background. The development of a vaccine to prevent infection with group A streptococcus (GAS) is ha...
The antiphagocytic surface M protein of group A streptococcus has been widely studied as the major c...
Despite the broad knowledge about the pathogenicity of Streptococcus pyogenes there is still a contr...
Despite the broad knowledge about the pathogenicity of Streptococcus pyogenes there is still a contr...
We investigated the efficacy of a synthetic Streptococcus pyogenes vaccine targeting two virulence f...
This study demonstrates the effectiveness of a novel self-adjuvanting vaccine delivery system for mu...
Background & objectives: To develop a broad strain coverage GAS vaccine, several strategies have...
Preclinical studies carried out over the last seven years by our group have focused on the developme...
Background & objectives: To develop a broad strain coverage GAS vaccine, several strategies have bee...
Traditional vaccines consisting of whole attenuated micro-organisms. or microbial components adminis...
A lipoamino acid based synthetic peptide, (Lipid Core Peptide, LCP) derived from the conserved regio...
Background. We investigated the lipid core peptide (LCP) system for mucosal vaccine delivery against...
Lipoamino acid-based synthetic peptides (lipid core peptides, LCP) derived from the type-specific an...
Lipid core peptide (LCP)-based group A streptococcal (GAS) vaccines incorporating numerous GAS M-pro...
The study reported here investigated the immunogenicity and protective potential of a lipid core pep...
Background. The development of a vaccine to prevent infection with group A streptococcus (GAS) is ha...
The antiphagocytic surface M protein of group A streptococcus has been widely studied as the major c...
Despite the broad knowledge about the pathogenicity of Streptococcus pyogenes there is still a contr...
Despite the broad knowledge about the pathogenicity of Streptococcus pyogenes there is still a contr...
We investigated the efficacy of a synthetic Streptococcus pyogenes vaccine targeting two virulence f...
This study demonstrates the effectiveness of a novel self-adjuvanting vaccine delivery system for mu...